Kai Zhang
- Cancer Research top 0.5%
- MicroRNA in disease regulation 36
- Cancer-related molecular mechanisms research 29
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 40
- RNA modifications and cancer 31
- Genomics and Chromatin Dynamics 22
- Cancer-related gene regulation 22
- Ubiquitin and proteasome pathways 16
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine 16
- Immunology top 2%
- Oncology top 2%
- Co-authors
- Yuegang ZuoYingming ZhaoShanshan TianLongbang ChenKaushik BanerjeeEnguo FanGuijin ZhaiZhi Yao
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Kai Zhang
489 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 196
- Cancer Research 1.8k
- Molecular Biology 6.2k
- Geriatrics and Gerontology 228
- Immunology 959
- Oncology 1.2k
Countries citing papers authored by Kai Zhang
This map shows the geographic impact of Kai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Zhang more than expected).
Fields of papers citing papers by Kai Zhang
This network shows the impact of papers produced by Kai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Zhang. The network helps show where Kai Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kai Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 11 | |
| 15 | 2023 | 1 | |
| 16 | 2020 | 34 | |
| 17 | 2019 | 53 | |
| 18 | 2019 | 113 | |
| 19 | 2016 | 3 | |
| 20 | 2013 | 128 |
About Kai Zhang
Kai Zhang is a scholar working on Cancer Research, Geriatrics and Gerontology and Molecular Biology, having authored 533 papers that have together received 11.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (40 papers), MicroRNA in disease regulation (36 papers), RNA modifications and cancer (31 papers), Cancer-related molecular mechanisms research (29 papers), Genomics and Chromatin Dynamics (22 papers), Cancer-related gene regulation (22 papers), Ubiquitin and proteasome pathways (16 papers) and Sirtuins and Resveratrol in Medicine (16 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (6.2k citations) and Geriatrics and Gerontology (228 citations). Kai Zhang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yuegang Zuo, Yingming Zhao, Shanshan Tian, Longbang Chen, Kaushik Banerjee, Enguo Fan, Guijin Zhai, Zhi Yao, Zhongyi Cheng and Shuzhen Zheng.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.